enrasentan has been researched along with Body Weight in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Engelberts, D; Jankov, RP; Kantores, C; Kavanagh, BP; McNamara, PJ; Murthy, P; Teixeira, L | 1 |
Bellini, G; Bernobich, E; Bertola, G; Bonavita, M; Cosenzi, A; Trevisan, R | 1 |
2 other study(ies) available for enrasentan and Body Weight
Article | Year |
---|---|
Therapeutic hypercapnia prevents chronic hypoxia-induced pulmonary hypertension in the newborn rat.
Topics: Animals; Animals, Newborn; Body Weight; Carbon Dioxide; Carboxylic Acids; Chronic Disease; Endothelin Receptor Antagonists; Endothelin-1; Female; Hematocrit; Hypercapnia; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Indans; Oxidative Stress; Oxygen; Pregnancy; Pulmonary Artery; Pulmonary Circulation; Rats; Up-Regulation | 2006 |
Antihypertensive treatment with enrasentan (SB217242) in an animal model of hypertension and hyperinsulinemia.
Topics: Animals; Blood Pressure; Body Weight; Carboxylic Acids; Collagen; Dietary Carbohydrates; Disease Models, Animal; Endothelin Receptor Antagonists; Fructose; Hyperinsulinism; Hypertension; Indans; Kidney; Male; Myocardium; Rats; Rats, Inbred WKY | 2002 |